DEVELOPMENT OF VACCINES - IMMUNOLOGICAL BASICS
MODELING OF PHARMACOKINETIC AND PHARMACODYNAMIC PROCESSES: A KEY TECHNOLOGY ALSO FOR PERSONALIZED DRUG THERAPY
RECOMMENDATIONS TO ASSESS THE QUALIFICATIONS OF INVESTIGATORS AND ADEQUACY OF TRIALS SITES - ARE THE PROPOSALS BY THE ETHICS COMMITTEES IN GERMANY RESPECTING ICH-GCP?
POTASSIUM-CHANNELS AS NOVEL TARGETS FOR ANTIEPILEPTIC PHARMACOTHERAPY
TRANSCELLULAR TRANSPORT OF CHLOROQUINE BY DOUBLE-TRANSFECTED MDCK CELLS EXPRESSING THE HUMAN UPTAKE TRANSPORTER OCT2 AND THE EXPORT PROTEIN MATE1
CLINICAL BIOMARKERS: IMPACT OF PRE-ANALYTICAL ASPECTS, ETHNIC FACTORS AND ANALYTICAL QUALITY STANDARDS ON THE RELIABILITY OF LABORATORY RESULTS
ELECTRONIC SUMMARY OF PRODUCT CHARACTERISTICS (E-SMPC): DATA MODEL OF DRUG DOSAGE AND PHARMACOKINETICS
IMPROVEMENT IN DRUG SAFETY THROUGH ELECTRONIC PRESCRIBING IN THE HOSPITAL-SETTING
INCREASED INCIDENCE OF CLINICAL EVENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH BAREMETAL STENTING AFTER DISCONTINUATION OF CLOPIDOGREL
INFLUENCE OF CO-MEDICATION AND URINE PH VALUES ON METHOTREXATE SERUM LEVELS IN CHILDREN PREDICTED BY THE GENERIC PHYSIOLOGY-BASED PHARMACOKINETIC (PBPK) MODEL PK-SIM®
DRUG INFORMATION SYSTEM FOR GENERATING DRUG ALERTS IN PATIENTS WITH LIVER DISEASES
DEVELOPMENT OF A SELECTIVE AND SENSITIVE HPLC/UV ASSAY FOR QUANTIFICATION OF RETINOIC ACID, 9-CIS-RETINOIC ACID, AND 13-CIS-RETINOIC ACID IN PLASMA AND TUMOUR TISSUES
GENERATING TETRACYCLINE INDUCIBLE MRP2 CELL-LINES
THE ROLE OF LYSINE 361 FOR OATP1B3-MEDIATED BSP AND TAUROCHOLATE TRANSPORT
CLINICAL PHARMACOLOGY OF THE NEW SELECTIVE PDE4-INHIBITOR ROFLUMILAST
CHRONOPHARMACOLOGY OF ROFLUMILAST: A COMPARATIVE PHARMACOKINETIC STUDY OF MORNING VS. EVENING ADMINISTRATION IN HEALTHY ADULTS
NO PHARMACOKINETIC INTERACTION BETWEEN THEOPHYLLIN AND ROFLUMILAST IN HEALTHY VOLUNTEERS
IDENTIFICATION OF PHARMACOLOGICAL ISSUES BY A CLINICAL PHARMACOLOGIST AND A PHARMACIST ON A SWISS UNIVERSITY HOSPITAL'S MEDICAL INTENSIVE CARE UNIT
IMPACT OF GENETIC AND NONGENETIC FACTORS FOR INTERINDIVIDUAL VARIABILITY OF SLC47A1 EXPRESSION IN HUMAN LIVER
BILIARY BILE ACID COMPOSITION IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS UNDER TREATMENT WITH URSODEOXYCHOLIC ACID
ABSENCE OF PHARMACOKINETIC INTERACTION BETWEEN ROFLUMILAST AND DIGOXIN IN HEALTHY VOLUNTEERS
DETERMINATION OF ENERGETIC PROFILES IN LIVING HUMAN CELLS BY FLUORESCENCE DETECTION
CURRENT CHALLENGE IN THE SAFETY OF CONDUCTING CLINICAL TRIALS: A NEW GLOBAL TOOL
IMPROVEMENT OF PHARMACOVIGILANCE IN CLINICAL TRIALS WITH IT-FILTER MECHANISM
ASSESSING QUALITY IN CLINICAL TRIALS IN CHILDREN - FIRST RESULTS
UNSPECIFIC BRONCHIAL REACTIVITY (UBR) IN A MODIFIED 2-STEP-TEST WITH CARBACHOL OR METACHOLIN
SUPRATHERAPEUTIC DOSES OF EVT 302, A NEW SELECTIVE MAO-B INHIBITOR, DO NOT PRODUCE CLINICALLY SIGNIFICANT INCREASES IN TYRAMINE INDUCED BLOOD PRESSURE RISE IN HEALTHY MALE SUBJECTS
EPIGENETIC APPROACHES TOWARDS THE PREDICTION OF BREAST CANCER DRUG TREATMENT OUTCOME
INFLUENCE OF PROPOFOL AND PHENOBARBITAL/SEVOFLURANE ON THE ENDOCANNABINOID ANANDAMIDE
PHARMACOKINETIC COMPARISON BETWEEN ORAL SUPPLEMENTATION REGIMENS WITH 25-HYDROXYVITAMIN D3 AND VITAMIN D3
POLYMORPHISMS LOCATED IN THE ORGANIC TRANSPORTER POLYPEPTIDE 1A2, 1B1, 1B3 AND 2B1 ARE NOT ASSOCIATED WITH BREAST CANCER RISK
TIME COURSE OF CYP3A INHIBITION WITH A REVERSIBLE (VORICONAZOLE) AND AN IRREVERSIBLE (RITONAVIR) INHIBITOR
EXPRESSION, LOCALIZATION AND FUNCTIONAL ANALYSIS OF OATP3A1 AND OATP5A1 IN MALIGNANT AND NON-MALIGNANT BREAST TISSUE
BCG-INSTILLATION FOR URINARY BLADDER CANCER, CONSECUTIVE TUBERCULOSIS TREATMENT WITH RIFAMPICIN. BISOPROLOL EFFICACY
INTERACTION POTENTIALS BETWEEN VITAMIN K ANTAGONISTS AND FOOD SUPPLEMENTS
ORAL ANTICOAGULATION IN AN OCTOGENARIAN, END-STAGE CANCER PATIENT WITHIN A CLINICAL NON-INFERIORITY TRIAL - CASE REPORT AND ETHICAL APPRAISAL
CAUSALITY ASSESSMENT OF 233 CONSECUTIVE SUSAR REPORTS FROM RECENT CLINICAL TRIALS WITH A DIRECT THROMBIN INHIBITOR REVEALS AN OVERWEIGHT OF THROMBOEMBOLIC EVENTS RELATED TO INSUFFICIENT EFFICACY
PRESCRIPTIONS FOR ANTI DEMENTIA DRUGS IN ELDERLY NURSING HOME RESIDENTS IN GERMANY
THE DPPIV INHIBITORS SITAGLIPTIN, VILDAGLIPTIN AND SAXAGLIPTIN DO NOT ALTER INNATE AND ADAPTIVE IMMUNE RESPONSES
ANTIHYPERTENSIVE DRUG THERAPY IN NURSING HOME PATIENTS
SELECTION OF DESIGNS AND PARAMETERS FOR CLINICAL TRIALS ON MOUTH RINSES
ENHANCED MICRODIALYSIS IN HUMAN PERIPHERAL TISSUES
INFLUENCE OF CYP2C19 AND CYP3A4 ON TILIDINE PHARMACOKINETICS AND METABOLISM IN HUMANS
GLUCOCORTICOID RECEPTOR GENE HAPLOTYPE STRUCTURE AND STEROID THERAPY OUTCOME IN IBD PATIENTS
IN VITRO EFFECTS OF INTESTINAL AND HEPATIC UPTAKE TRANSPORTERS ON TALINOLOL UPTAKE
HEPATIC UPTAKE AND PHARMACOKINETICS OF THE MRI CONTRAST AGENT GADOXETATE IN HEALTHY SUBJECTS, ROLE OF OATP1B1, OATP1B3 AND ABCC2
KNOWLEDGE DEFICITS OF NURSES INVOLVED IN ROUTINE DRUG HANDLING ON PAEDIATRIC WARDS
INVESTIGATIONS TO DISTRIBUTION OF METOPROLOL IN HUMAN AUTOPSY MATERIAL
COMPUTERISED CLINICAL DECISION SUPPORT FOR SWITCHING DRUGS AT HOSPITAL DISCHARGE
PHARMACOKINETICS, PHARMACODYNAMICS AND BIOEQUIVALENCE OF DEXAMETHASONE LIQUID AND TABLET FORMULATIONS
EXPRESSION AND LOCALIZATION OF SLC22A25 IN HUMAN LIVER
QUALITY AND “PSEUDOQUALITY” OF CLINICAL STUDY CONDUCT - IMPACT ON OUTCOME
BIOAVAILABILITY OF TROSPIUM CHLORIDE (TC) IMMEDIATE RELEASE (IR) COMPARED WITH AN EXTENDED RELEASE (ER) FORM UNDER EVERYDAY CONDITIONS
EFFICACY OF AMBULANT RADON BALNEOTHERAPY IN RHEUMATIC DISEASES
DETECTION OF DRUG UNDERDOSAGE IN ELECTRONIC PRESCRIPTIONS
IMPACT OF A COMPUTERIZED CLINICAL DECISION SUPPORT SYSTEM ON DRUG THERAPY IN A TERTIARY HOSPITAL
TRANSPORT OF L-ARGININE AND ASYMMETRIC DIMETHYLARGININE (ADMA) BY HUMAN ORGANIC CATION TRANSPORTERS 1 AND 2 (OCT1 AND OCT2)
POTENTIALLY INAPPROPRIATE MEDICATION IN A GERMAN ELDERLY COHORT
THE EFFECT OF CYP2C8*3 POLYMORPHISM ON PHARMACOKINETICS AND PHARMACODYNAMICS OF REPAGLINIDE
ANTIPLATELET EFFECT OF CLOPIDOGREL AFTER SELECTIVE DOSE-ADJUSTMENT IN PATIENTS WITH HIGH ON-TREATMENT PLATELET REACTIVITY ON STANDARD-DOSE CLOPIDOGREL FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH STENT IMPLANTATION
MEDICATION REGIMEN COMPLEXITY AT DISCHARGE FROM INTERNAL MEDICINE
LONG QT SYNDROME AND TORSADE DE POINTES AS ADVERSE DRUG REACTIONS - PRELIMINARY RESULTS FROM THE NATIONAL PHARMACOVIGILANCE-CENTER BERLIN (PVZ-FAKOS)
CASE REPORT: DISORDER OF HEPATIC FUNCTION BY MEDICATION OF EXENATIDE AND FLUVASTATIN - ADVERSE DRUG REACTION (ADR) - RELATED HOSPITAL ADMISSION